# Wujinfangzhou

Developer of AI-powered anti-aging drugs.

Developer of AI-powered anti-aging drugs.

Canonical: https://uniquebase.ai/companies/UB-C10495
Stable identifier: UB-C10495
Snapshot captured: 2026-10-15T14:23:27.067Z
English updated: 2026-10-15T19:46:00.018Z

## Funding

Listed 3 records.

- 2026-07-17 · Tens of millions of RMB · Seed · Boyu Venture Capital, 九合创投, 星连资本, 砺思资本
  > On 2026-07-17, according to Xiniu Data, Wujinfangzhou completed seed financing, raising tens of millions of RMB. Investors were lead investor Jiuhe Venture Capital, participating investor Monolith, participating investor Boyu Capital, participating investor Xinglian Capital. The company is a developer of AI-powered anti-aging drugs. (translated source brief)
- 2026-07-07 · Undisclosed · Equity · 扬州未来光锥股权投资合伙企业（有限合伙）
  > On 2026-07-07, according to Xiniu Data, Wujinfangzhou completed equity financing for an undisclosed amount. Investors were Yangzhou Weilaiguangzhuiguquan Investment Partnership (Limited Partnership). The company is a developer of AI-powered anti-aging drugs. (translated source brief)
- 2026-05-18 · Tens of millions of RMB · Seed · Boyu Venture Capital, 九合创投, 扬州未来光锥股权投资合伙企业（有限合伙）, 砺思资本
  > On 2026-05-18, according to Xiniu Data, Wujinfangzhou completed seed financing, raising tens of millions of RMB. Investors were lead investor Monolith, participating investor Boyu Capital, participating investor Jiuhe Venture Capital, participating investor Weilaiguangzhui. The company is a developer of AI-powered anti-aging drugs. (translated source brief)

## Valuation

Listed 3 records.

- 2026-07-17 · amount unavailable · Seed · Boyu Venture Capital, 九合创投, 星连资本, 砺思资本
  > On 2026-07-17, according to Xiniu Data, Wujinfangzhou completed seed financing, raising tens of millions of RMB. Investors were lead investor Jiuhe Venture Capital, participating investor Monolith, participating investor Boyu Capital, participating investor Xinglian Capital. The company is a developer of AI-powered anti-aging drugs. (translated source brief)
- 2026-07-07 · amount unavailable · Equity · 扬州未来光锥股权投资合伙企业（有限合伙）
  > On 2026-07-07, according to Xiniu Data, Wujinfangzhou completed equity financing for an undisclosed amount. Investors were Yangzhou Weilaiguangzhuiguquan Investment Partnership (Limited Partnership). The company is a developer of AI-powered anti-aging drugs. (translated source brief)
- 2026-05-18 · amount unavailable · Seed · Boyu Venture Capital, 九合创投, 扬州未来光锥股权投资合伙企业（有限合伙）, 砺思资本
  > On 2026-05-18, according to Xiniu Data, Wujinfangzhou completed seed financing, raising tens of millions of RMB. Investors were lead investor Monolith, participating investor Boyu Capital, participating investor Jiuhe Venture Capital, participating investor Weilaiguangzhui. The company is a developer of AI-powered anti-aging drugs. (translated source brief)

## Revenue

No revenue records are listed yet.


## Team

- [Zhao Simiao](/people/zhao-simiao)

## Products

No published products profiles are linked yet.

## Investors

- [Boyu Venture Capital](/institutions/boyu-venture-capital)
- [九合创投](/institutions/UB-I683)
- [扬州未来光锥股权投资合伙企业（有限合伙）](/institutions/yangzhou-weilaiguangzhuiguquan-investment-partnership-limited-partnership)
- [星连资本](/institutions/xinglian-capital)
- [砺思资本](/institutions/lisi-capital)

## Sources

- No source links are available for this profile.
